Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks.
Diekmann
Fritz
F
Campistol
Josep M
JM
D065095:Calcineurin Inhibitors; D002908:Chronic Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D011183:Postoperative Complications; D011507:Proteinuria / Q000188:drug therapy* / Q000378:metabolism; D020123:Sirolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D020123:Sirolimus